A large randomized study published Sunday finds that 70% of women with early-stage invasive breast cancer no longer need chemotherapy, using the results of a commonly used genomic test. This practice-changing finding will spare a lot of unnecessary chemotherapy in patients with breast cancer.

Thousands of breast cancer patients could now safely avoid chemotherapy thanks to a major study of women with moderate risk of recurrence.


About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →